HOME test kits proved their value during the height of the Covid-19 pandemic as there came a point when hospitals were turning away patients who needed to be tested and treated. The ability to get tested for Covid in the comfort, privacy and safety of the home helped symptomatics know their Covid status sooner, with accuracy similar to a rapid antigen test in a laboratory. A negative test ensured peace of mind; a positive test meant that necessary treatment can be done earlier.
MOHS Analytics was one of the first to introduce rapid antigen tests for Covid in the Philippines. With the growing acceptance of home test kits as an essential tool for healthcare, MOHS Analytics set up an arm, MOHS Diagnostics MD to expand its line of globally accepted home test kits to include malaria, urinary tract infection, and dengue. Under development is a test for leptospirosis.
MOHS Diagnostics has also introduced an ovulation test kit, which while not detecting disease, will also be a helpful tool for women who want to get pregnant.
“MOHS has grown quickly by addressing market gaps and meeting consumer demand through highly innovative products,” says Chief Innovation Officer Don Paolo San. “Being attuned to the market helps us to deliver what is needed with game-changing technologies.”
Timely detection of disease is crucial for effective health management and preventing the spread of disease. Diseases such as malaria, dengue, and leptospirosis can be fatal if not properly treated as soon as possible. MOHS Diagnostics Home Test Kits allow early identification of potential health concerns, enabling prompt action and care.
But home test kits can only be effective if they are available, accessible, and affordable when needed.
MOHS diagnostic test kits are available without prescription and at affordable prices at over 2,500 retail outlets nationwide, from giant national pharmaceutical chains to smaller regional chains.
“There is a growing realization that disease detection can be quickly and accurately done at home such that the sick can start early treatment and prevent the spread of disease. We are making accurate and affordable self-tests accessible to the Filipinos and this is our contribution to the improvement of the healthcare system in the Philippines,” says MOHS CEO Mike Hortaleza.
At the first symptom of illness, home test kits will provide the sick with essential health insights, without the need for travel or clinic visits. These empower the sick and their caregivers to make informed decisions about their well-being and to seek professional help as warranted.
Image credits: MOHS Online